Skip to content

Clinical trials

Observational Genetic Diseases, Inborn trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Observational Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20151
20171
20194
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated2
Enrolling by invitation1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company2
Arbor Research Collaborative for Health1
CSL Behring1
Editas Medicine, Inc.1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Friedreich's Ataxia Research Alliance1
HemoShear Therapeutics1
REGENXBIO Inc.1
Shire1
Spark Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn14
Metabolic Diseases4
Metabolism, Inborn Errors3
Musculoskeletal Diseases3
Bone Diseases2
Brain Diseases2
Brain Diseases, Metabolic, Inborn2
Central Nervous System Diseases2
Dwarfism2
Hematologic Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.